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prr old, resppelive,? (9 = NS). Among the 337 pa,ienB 
tatod, ,,lore wlrc “0 r”mp,ica*ions of m,ocardial inert- 
Iion or death. The most cwmmm rardiir ride effect was 
ckst pain, which eccurred in 21 1217oa) f the IO1 patients 
aged 270 years and in 64 (27%) of the 236 padents <70 
years (p = NS). Andnopbylliw was required to rewSe 
Coronnry a~ery disease is a m+ior cauw of morbidity and 
mortality in elderly patients (t-3). The arser?menl of core- 
nary artery disease in lhis clinical palicn, sub%, can be 
difficult because of inadequate dewipfion of or fadure ,o 
report cardiac syrptoms. and bccaurc of a” increased 
frequency of noncardiac ailments ,ha, may overahaaaw 
cardiac symptomafology. Some older pa!wnrs are unable IO 
achieve adequaie levels of cxcrcisc $,rew necessary lo tes, 
cardiovascular reserve. thus reducing ihe accuracy of excr- 
cise electrocardiography (ECG) and radonuclide proce- 
dures. Clearly. an alternative dlagnwic trs, procedure 
would bc useful. parlicularly because older patienls tend 10 
have more wvere and extensive coronary disease than do 
younger paucntr (2). 
In,rwenou~ dipyridamole /s a p&z”, coro”xy vacodila- 
,or used ,o de,.%, abslruclive coronary diwv and if c”” 
produce regtana, coronary hypoperfuwn I” paloeots with 
\,eno,tc cwonsry anericr tba, can bc dclccled b) thallium 
4nligotphy (C9). The ,CI, may be particularly well suited 
for ,he ~valua,ion of older pa,ien,\. However, advent drug 
rmckm are known 10 be more common in Ihe elderly ! IO). 
and the pmential use of a powerful coronary vasoddn,or 
needs 10 be lead. The aim of :hn srudy was 10 BSX ,he 
\ak,y md diagnosfic accuracy of dlpyridamolc-lhallium 
imagmg I” a c&sccu,ivc xric\ of 101 patic”,> aged 270 
years and ,o compare the resu,,s with those “blamed I” a 
c”n*ecu,ivc wies of ?36 palicnts <70 years. 
S,ady p&en&. WC ,cc,cd B xrie\ “f 337 w”~~cu,~v~ 
pauems referred for the evaluar~on of iuwaed or proved 
337 patients underwent dip;ridamole-thallium imaging. 
IO1 were ~70 years of see (75 + 4.0) and 236 oatients were 
~70 years (57 r 9.3). Tierc were 201 men ad 136 women; 
their clm~cal and angiographic characteristics are described 
in Table I. Beta-adrenergic and calcium channel blocking 
agents were shghdy hut significantly less commonly used in 
the elderly. Paticnta with uncontrolled unstable angina. 
overt congestwe hcan failure or severe bronchoapastic 
pulmonay disease were excluded. 
Dipyridamote infusion protocol. Dipyridamole infusion 
was performed in the mormng with the patient fasting and in 
the supine position. Baselme heart rate and hload pressure 
were recorded and the ECG was continuously monitored. 
Dipyridamole was infured et a rate of 0.56 mw’kg body 
weight over4 min through an indwelling Teflon catheter. The 
hean rate, blood pressure and ECG were recorded each 
minute for a total of IO mill from the ~1x1 ofthc infusion. At 
the termination of infusion, the patient was instructed to sit 
at the bedside and 10 actively swing the legs for 4 min. Two 
millicuneb of thallium-201 was injected through the intrave- 
noes line and Rushed with heparinired normal saline bolu- 
tion. and imaging war performed within 5 min of rhc thal- 
lium-201 injection. The occurrence of symptoma during or 
after the dlpyridamol: infusion v:as noted. end parenten? 
aminoohrlline and nirroelvccrin were available 10 reverse 
impor& adverse side ek;cts. 
Thallium-201 imaging and aoatysis. Planar thallium imag- 
ing was performed within 5 min of the thallium-201 injection 
using a smuti Qcld of view gamma camera (Elscint) equipped 
with a low energy. high resolutmn. parallul bole colbmstor. 
Sequential images in the 45~ left anterior oblique, anterior 
and left lateral views were acwired at the 80 keV ohotopeak 
with a 30% window. and stored in a 256 x 256 bite matrix. 
Each imaee was acauircd for IO min (aooroximatelv 5OO.MKt 
counts). Lklayed i&es in the same fws were obtained 4 
h later. Both sets ofprocessed images were photographed on 
black and white 8 X 10 inch X-ray film. 
T/w immediare oosrdiwridomole and d&wed imonrs 
ww displayed side. by ridi and interpreted by-two expri- 
enced observers lB.R.C.. H.G.) without prior knowledge of 
the patients’ clinical history or angiographic results (I 1.12). 
The thallium images were divided into five approximately 
equal left ventricular segments using previously described 
techsiques (t3). Each segment was coded as normal or as 
having a reversible or fixed thallium defect. Thallium scans 
with reversible or fixed defects were classified aa abnormal. 
Coronary aogiography. Within 2 weeks of the dipyrida- 
mole.thallium study, selective right and left coronary angi- 
ography was obtained in multiple projections using a percu- 
taneous traosfemoral approach in 37 ofthc 101 patients 270 
years old and in 105 cd the 236 patients <70 years old. Each 
coronary angiogram was interpreted by a cardiologist who 
was unaware of the thallium imaging results. An intraluminal 
stenosis ~70% was considered abnormal wept for the left 
main segment in which a stenusis ~50% was considered 
important. 
Statistical analysis. The rexdts are expressed as meao 
values i SD. Tbc sensitivity of the dipyridamole-thallium 
images was defined as the ratio of the number of the 
true-positive to woe positive plus false negative results, and 
specificity is defined as the ratio of the oumber of ttue 
negative to true negative plus false positive results. Frequen- 
cies were compared by chi-square analysis. 
Results 
Side effects (Table 2). The incidence of side elkts was 
38.6% ;ind the frequency was similar to older and younger 
Aminophylline or nilroglycerin requiremenL5. One of 
Ihe\e age”& wan required to reverse cardiac or noncardiac 
ride cffcct\ m 18 (IS%1 and 40 117%) ofthc paticntS aged ~70 
ana X71r rears. resoecwelv lo = NS). Thirteen oatients 
113Ul npcd >70 y&s and Zi ,tients II I%) aged ~73 years 
received aminophylline to reverse cardiac side effects: it was 
used in 2 patvznt~. aged >70 years and 9 patients <‘O years to 
revene nonsard~& iide .~ffccts such as headache or lighthea- 
dednccs. 
iion, sustained arrhythmia o; death among;he 337 patients 2 weeks of.testing was available in 142 (42%) of the 337 
studied. The incidence of side effects was cxammcd accord- patients. Among ?!!e 101 patients aged 270 years. the 
ing to age decade and ranged from 31 to 40% among Ihe IS. sensitivity of intravenous dipyridamale-thallium imaging for 
35.70, I16,!90 and I I patients aged ~40.40 to 49,50 to 59. obstructive coronary artery disease was 86% (25 of 29). 
M) to 69. 70 to 79 and 80 to 89 years. respectwely (Fig. I). Among the four false negative results, three occurred m 
The incidence of cardiac snde etTects, defined as dipynda- panems with smgle vessel and one m a patient wth two 
mole-induced chest pain or ST segment depressloo 11 mm. vessel coronary disease. The sensitivity of dipyridamole- 
ranged from 23 to 33% and occurred with similar frequency rhallium imaging in the older pztienls was similar to Ihe 84% 
among the d&rent age groups. sensitivity (68 of 81) observed in Ihe younger patients (p = 
Nonwrdiac side efkets. Headache was the most common NS). The specdicity of inlravenous dipyridamole-thallium 
noncardiac side effect. Nausea. dizziness and flushing oc- imaging was 75% (six of eight) in the older patients. Two of 
curred to a lesser extent (Table 2). The Incidence of noncar- these eight patients without swificant coronary artery dis- 
disc side effects was similar in both ap groups except for ease ;_7O% had a positive dipyridamole-thallium image: one 
nausea. which was significantly more frequent in older had a 50% lesion of a diagonal branch and the other had two 
patients (p = 0.032). Systolic blood pressure decreased from 40% $tenoses ofthe left anterior descending coronary artery. 
144.6 ? 23.8 to 129. I ? 19.2 mm Hg (It).?% decrease) withm The 75% speuficity of dipyridamole-thallium imaging in the 
10 min ofthe dipyridamole infusion in the older patients. and older patients was imilar to the 70% (I6 of 23) observed in 
from 134.4 ? 19.1 :o 122.5 + 16.6 mm Hg (8.9% decrease. younger patients. 
p = NS) in the younger patients, respechvely. The maximal The sensitivity and specificity of d!pyridamale-induced 
increase in heart rate war 13 z 3 keatsfmin tI8.8% increase) ST sehment depression ~1 mm for ohstruclive coronary 
in the older patients and 20 + 4 beats/& (27.7% increase) in disease was 13.5% (IS of III) and 90.3% (28 cf31). rewec- 
the younger patients. respective!y !p = NSI. twciy. The sensitivity was 25.2% (28 of I I I) and specif!rity 
CardIne side elfeets. The most common cardiac side effect wBF 80.6% (25 ot 31) When the eiii paIn: WzIirls :et ?! ST 
was chest pain. which was typical of angina in 64 (77%) of segment depression ~0.5 mm. 
the 83 oatients (Table 2). Concomitant ischemic KG 
changesiST depr&ian zl’mm) occurred in 18 (28%) ofthe 
64 patients with angina. A severe ischemic response, defined 
as severe, recurrent or persistent chest pain lasting 2 IS min 
and assouated with ischemic ECG changes, occurred in 
eight patients. The thalbum scan was abnormal in seven of 
these eight patiems. Of seven patients who underwent 
coronary angiography. three had three vessel. three had two 
vessel and one patient had rmgle vessel coronary disease. 
One of the eight patients required emergency coronary 
angiography and coronary angioplasty (141: the remaining 
Diseu88ion 
The increacing age of the North American population 
combined with a relatively high prevalence of coronary 
artery diseae in the elderly has generated an increased 
werest in !he noninvasive detection of these patients. Iden- 
tihcatmn of older patients with lschemx heart disease is 
importmt hecauce. in general, they tend to have more 
diffwc and extensive coronary disease compared with 
younger pal ems (2). they are at increased operative risk for 
cardiac and noncadiac procedures (IS.lbl and appropriate 
medical and surgical treatmenl for specific patients can 
prolong survival and improve quality of life (3.15). Unfortu- 
ozie:y, exerusi- icrimg. one oi rbc row commonly used 
noninvaaive tesis to screen for coronary artery disease. may 
yield suboptimal results in older patient?. panicularly when 
cnhopcdic. arthritic or neurologic limitations preclude ade- 
quate exercise work loads. Intravenous dipyridamole is a 
pant coronary vasodilalor shown to increase coronary 
blood Row approximately two to four times baseline when 
administered in a dose of 0.14 mglkg per min for 4 min 
~4.7.17.18). Injection of thallium-201 after coronary vasodi- 
lation an demonstrate regional litTerames in coronary 
blood Row when obstructive coronary artery disease is 
orenat and has been shown io bc a uscfii! diaenostic and 
&gnostic lest for coronary artery disease (5,6,8.19). 
Side effect rrofile. Our data show that intravenous diw- 
ridamole-thal~um imaging is safe in en elderly pop&i& 
with a side effect pm& similar to that observed in a younger 
population using an intravenous dose of 0.56 mglkg. The 
incidence rates of cardiac and noncardiac side eLcts in the 
two groups are comparable, even though older patients arc 
known to be more sensitive to cardioactive drug therapy. 
The safety of the dipyridamolc test is enhanced by the ability 
to partially reverse adverse pharmacologic effects with pa- 
renteral aminophylline and nitroglycerin (7). 
The incidence of side effects in our series is similar to that 
observed in previous studies (4,201. Chest pain is the most 
common side effect. usually similar in character to the chest 
pan experienced by the patient before testing. Alhro et al. 
(4) showed that angina was ,igniiicantly less frequem or 
severe than with exercise stress in a seies of patients who 
underwent hoth forms of testing. 
ECG. A limitation of intravenous dipyridamole-thallium 
imaging is the lack of physiologic information and relative 
absence of ECG markers of myocardial ischemia such as 
ST segment depression 2-I mm. In our series, only 8% of 
patients had dipyridamol&duced S’i segment depression 
>I mm. less than the 19% observed by Homma e, al. (20) 
but similar to tiie 3% and lO?h reported by Albm et al. (4) 
and Leppo et al. IS). respectively. This relatively low in& 
dcnce of KG changes may be related in part to the 
continaation of cardioactive medalion in many of our 
patients. The magnitude of bemodynamic responsiveness 
and ECG changes after dipyridxwle is blunted by cardio- 
active medication (21). In clinical practice, it is often diffi- 
cult to discor:iince cardioactive medication in the days 
preceding testing because of physician preferences. con- 
traindication to drug discontinuation and time and cost 
considerations in hospitalized paoents awaiting a surgical 
procedure. 
Severe isehemic responses. The intravenom dose of 0.56 
mglkg dipyridamolc is associated with a small but recognized 
incidence of severe ischemic responses (14). In our older 
patients the incidence of severe irchcmic responses was 
similar to that in younger patients. One patient required 
emergency cardiac calheterization and coronary angioplastv 
(14); the remaining seven patients responded 10 intravenous 
aminophylline and sublingual nitroglycerin. The incidence of 
severe irchemic responses was increased when the test 
indication was to evaluate coronary Row reserve in patients 
with recently controlled unstable angina. 
Intrawaous dipyridamole is a potent coronary vasodila- 
tar that occarionally can cause a coronary anery steal. 
resulting in ECG and scintigraphic abnormalities. Picano et 
al. (22) reported reversible regional wall motion defects 
using echocardiography in 72% of 25 patients with angiogra- 
phically documented coronary artery disease after intrave- 
nous dipyridamole infusion. thereby providing indirect evi- 
dence f& functional &hernia. 
Diuowtic aeeoraev of intravenous dirvridamole.thallium 
im&. The sensiti~ty and specificity if intravenous dipy- 
ridamole-thallium imaging in our older patients were similar 
to those in younger patients in our series and were compa- 
rable with real& reported with exercise thallium imaging 
(23). The specificity of intravenous dipyridamole-thallium 
imaging in our series was based on a relatively small sample 
size: a larger number ofpatients would need to be studied IO 
validate this observation. The sensitivity of intravenous 
dipyridamole-thallium imaging can be increased Further us- 
ing bigber doses of intravenous dipyridamo!c. Piano et al. 
(24) reported new regional wall motion defects in 15 of 74 
p&r&s with coronary anery disease who had an initially 
negative dipyridamole echocardiotwphic test at P dose of 
0.56 mglkg icfused over 4 min and whose test basme 
abnormal using a higher dose of 0.84 mglkg infused over IO 
min. In their wies, side effects were not signilicantly 
increased wing the higher dose, althosgl! the patients wre 
careful:y selected and the higher dose WF used only in 
patients who had an initially negative ~esl. The safety of 
using higher doses of dipyridamole in older patients or in 
patients early after an acute ischemic syndrome remains to 
be determined. As of January I. IYS7, >5,OM patienls have 
undergone intravenous dipyridamole imaging pmcedures. A 
small number of deaths have been reported, at least two of 
which were the result of severe myocatiial ischemia or 
necrosis, (Personal communication March 1987; Dr. Alan 
Ranhosky. Boehringer-lngelheim Pharmaceutical). 
Clinhl Implications. Dipyridamole-thallium imaging is a 
safe. noninvasive method of evaluating the presence and 
significance of obstructive coronary artery disease and pro- 
vides a reliable alternative to exercise stress in older patients 
unable 10 exercise. However. the technique can produce 
severe ischemic responses in a small minority of psrients. 
particularly those with recenl unstable angina. Aminophyl- 
line administration will abolish the ischemic respocse in 
most patients. 
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